I suspect there could be heavy selling on this one,as a tax loss, as we approach end of financial year.any thoughts, I hold.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025